Protocadherins are a subgroup of the cadherin superfamily of calcium-dependent cell adhesion proteins. They are primarily expressed in the nervous system and play critical roles in neural development, including neuronal migration, axon guidance, and the establishment of synaptic connections. Protocadherins are encoded by large gene clusters, notably the PCDHα, PCDHβ, and PCDHγ clusters in humans, which allow for a high diversity of isoforms through alternative splicing and promoter usage.
These proteins typically possess extracellular cadherin domains involved in homophilic interactions, a transmembrane domain, and a cytoplasmic domain that may interact with intracellular signaling or scaffolding proteins. Unlike classical cadherins, protocadherins often exhibit more restricted expression patterns and are thought to contribute to the identity and connectivity specificity of individual neurons.
Protocadherins are conserved across vertebrates, and their genomic organization suggests a role in generating molecular diversity essential for complex neural circuit formation. Mutations or dysregulation in protocadherin genes have been associated with neurological disorders, including epilepsy, autism spectrum disorders, and schizophrenia, though causal relationships are still under investigation.
Accurate information is not confirmed regarding the involvement of protocadherins in non-neural tissues, although some studies suggest roles in immune regulation and cancer progression; further research is required to substantiate these findings.